News Digging > Science > Sydney Spinout Secures $273M Deal to Develop Psychiatric Drugs
Sydney Spinout Secures 3M Deal to Develop Psychiatric Drugs
Sydney Spinout Secures $273M Deal to Develop Psychiatric Drugs,Compounds developed by Professor Michael Kassiou’s drug discovery team for Kinoxis Therapeutics will be used to target oxytocin receptors with the aim

Sydney Spinout Secures $273M Deal to Develop Psychiatric Drugs

Compounds developed by Professor Michael Kassiou’s drug discovery team for Kinoxis Therapeutics will be used to target oxytocin receptors with the aim